Grantable
Recent Ad Hoc Grant: ZEPIKActive - dCas9 activator for KMT2D function restoration · KABUKI SYNDROME FOUNDATION
$45,132
ZEPIKActive: Use of dCas9 Activator to Restore Normal KMT2D Function Funder: Kabuki Syndrome Foundation Award Date: March 2025 Award Amount: $45,132.96 Status: Recently funded Overview This study explores whether dCas9-activated transcription can compensate fo…
Welcome to Grantable
Sign in to start building your grant-ready profile
or
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.